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Interactions of doxorubicin and cis-platin in squamous carcinoma cells
in culture
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Summary Doxorubicin (DXR) has a positive inoculum effect and penetrates poorly into the core of
multicellular tumour spheroids (MTS). Cis-platin (DDP) displays neither of these characteristics. We
evaluated whether combining these 2 agents would influence the cell kill effect at a tumour mass level. MTS
were produced from a PC-10 squamous lung carcinoma cell line. MTS were exposed to either drug first for
h with different intervals between exposure. Cells were then trypsinized to a single cell suspension and
subjected to clonogenic assay. Combination effects were analyzed by median effect plot analysis. The more
MTS ml-' medium, the lower the cell kill effect of DXR. Simultaneous exposure to the 2 drugs was
synergistic. DXR exposure first followed by DDP was less efficacious than, or the same as, the simultaneous
exposure. In contrast, DDP followed by DXR was more efficacious with the best cell kill at a 1 h interval
between each drug. This phenomenon was observed even at non-toxic doses of DDP. The fluorescent
microscopic study of DXR indicated that prior exposure of MTS to DDP resulted in increased DXR
penetration into the MTS core leading to heightened synergism with this sequence. These data suggest that
the proper combination of DXR plus DDP should be in sequence with DDP first. Clinical, toxicological and
pharmacological trials of DDP administration first, followed by DXR, are warranted.
Doxorubicin (DXR) and cis-platin (DDP) are both highly
active anticancer agents widely used in the treatment of
human cancer. We introduced a combination of these 2
agents, termed A & P (adriamycin and platinum) (Vogl et
al., 1976), which has become the basis, by adding more
drugs, for the treatment of patients with ovarian cancer,
small cell lung cancer and other neoplasms. Recently, we
have demonstrated that DXR has a positive inoculum effect
in vitro and loses efficacy at high cell densities, whereas DDP
does not (Ohnuma et al., 1986). Moreover, we have shown
that DXR penetrates poorly into the core of multicellular
tumour spheroids (MTS) whereas DDP shows no such
penetration gradient (Inoue et al., 1985). These pharmaco-
logical differences at the tumour mass level indicate that
DXR should be best used when tumour size is small and cell
density low. Therefore, we hypothesized that the proper
sequence of A & P should be DDP first, followed by DXR,
rather than vice versa. This communication sets forth the
experimental proof of our hypothesis and elucidates a pos-
sible mechanism for this effect.
Materials and methods
Human tumour cell line
PC-10 squamous lung carcinoma cell line was used in these
experiments (Kinjo et al., 1979). Cells were maintained as a
monolayer in RPMI-1640 medium (GIBCO, Grand Island,
NY), supplemented with 10% (v/v) heat-inactivated foetal
bovine serum (FBS) (Gibco) at 37"C in a 5% CO2/95%
humidified air atmosphere. These cells were subcultured after
trypsinization with 0.2% trypsin (Type III from bovine
pancreas, Sigma, St Louis, MD) and 0.01% EDTA in
Hank's balanced salt solution (HBSS) (Gibco).
Growth of MTS
MTS were developed by a liquid overlay culture technique
(Yuhas et al., 1977), as described previously (Kohno et al.,
1987). Aliquots of I x 105 cells in 10ml of complete culture
medium were placed in 100mm plastic Petri dishes (Falcon
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1005, Cockeysville, MD) previously coated with 0.5% agar
(Noble, Difco, Detroit, MI) in the same culture medium.
These cells were incubated in 5% CO2/95% humidified air at
37°C. When MTS were formed, they were transferred to a
new agar dish once a week.
Drugs
DXR was purchased from Adria Laboratories, Columbus,
OH and DDP was purchased from Bristol Laboratories,
Syracuse, NY.
Conditions of drug exposure and determination of cell
survival
After 3 weeks of culture, MTS with a diameter of 700 um
were formed. MTS with a diameter > 700,um tended to
develop a necrotic core. MTS with - 700gm were trans-
ferred into a new agar-coated multiwell plate (Falcon 3046,
Becton Dickinson Labware, Lincoln Park, NJ) containing
2ml fresh medium. After a preincubation period of 24h,
MTS in different densities were exposed to graded concen-
trations of DXR or DDP for I h. The MTS were then gently
washed twice with PBS (Gibco). The single cell suspensions
were made by exposure to the 0.2% trypsin and 0.01 %
EDTA solution for 10min at 37 C, followed by mechanical
disaggregation through repeated pipetting. These cells were
washed once with the medium and resuspended in the
medium. One tenth ml aliquots of cell suspension (3,000
cells) were seeded on 60mm Petri dishes (Corning 25011,
Corning, NY) containing 0.5% noble agar in complete
culture medium for clonogenic assay (Kuroki, 1974). The
dishes were incubated for 10 days at 37"C, under 5% CO2-
95% humidified air. Colonies of .50 cells were counted.
The plating efficiency of untreated cells under these con-
ditions was -40%. The dose response curve was drawn by
plotting the number of colonies as a percentage of control
against each drug concentration. Each experiment was done
in triplicate and repeated at least 3 times.
Combination experiments were carried out as a I h expo-
sure to each drug. After drug exposure, cells were washed
free of drug and incubated in drug-free culture medium for
different intervals. After the indicated incubation time per-
iods, the MTS were exposed to a second drug for 1 h,
washed free of drug. trypsinized to a single cell suspension
and subjected to clonogenic assay.
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Data analysis
The efficacy of the combination was determined by the
median effect plot analysis using an IBM PC microcomputer
system (Chou & Talalay, 1984, 1987; Chou, 1985). This
method involves plotting dose-effect curves for each drug for
one or more multiple-dilutions and fixed ratio combinations
of the drugs using the median effect equation: fa/fu=
(D/Dm)m, where D is the dose, Dm is the dose required for
50% effect (e.g. 50% inhibition of PC-10 cell's colony
formation), fa is the fraction affected by the dose D, fu the
fraction unaffected and m a coefficient signifying the sigmoid-
icity of the dose-effect curve. The dose-effect curve was
plotted using a logarithmic conversion of this equation which
determines the m and Dm values. Based on the slope of the
dose-effect curves, it can be decided whether the agents have
mutually exclusive effects (e.g. similar mode of action) or
mutually non-exclusive effects (e.g. independent mode of
action). A combination index (CI) was then determined using
the equation:
CI-(D)1 + (D)2 + a(D)
I(D)2
(Dx)1 (Dx)2 (Dx)1(Dx)2
where (Dx)1 and (Dx)2 are the doses of drugs 1 and 2,
respectively, required to produce x00 effect individually.
(Dx)1 and (Dx)2 for x% cell kill can be determined by
drawing a least square regression line on the computer
graphic system. (D)1 and(D)2 are the doses of drugs 1 and 2,
respectively, which are required to produce the same x%
effect in combination. If the drugs are mutually exclusive,
then a is 0: if mutually non-exclusive, then a is 1. When
CI= 1, the interaction was considered additive; when CI< 1,
synergism was indicated; and when CI> 1, antagonism was
indicated.
Fluorescent microscopy
MTS of - 700,m diam. were treated with 2 x 10 M of
DXR alone or combination of DXR and 2 x 10-I M DDP at
1 h intervals of each drug, which was the best cell kill
sequence. The treated MTS were washed with ice-cold PBS
once, embedded in OCT compound (Miles Scientific, IL) and
frozen rapidly. Thin sections (5gm) were made using a
cryotome (Lipshaw Elect, MI). DXR fluorescence was
observed under a fluorescent microscope equipped with epi-
illumination (Nikon, DS-EPI-FL, Japan) using G-Green
(excitation filter 535-550jgm, barrier filter 580gm). In this
system endogenous fluorescence from control MTS (ones not
exposed to DXR) could not be recognized.
Results
The influence of MTS density on DXR- or DDP-induced
cell lethality is shown in Figure 1. For DXR-induced cell
lethality, the higher the density of MTS, the lesser the cell
kill effects and dose-response curves of DXR progressively
flattened at high drug concentrations. In contrast, DDP gave
entirely different dose-effect curves; cell survival curves for
high MTS density and low density overlapped each other
and there was progressively increasing cell kill at increasing
doses.
Time dependent cell lethality of the combination of DXR
plus DDP at low MTS density is illustrated in Figure 2.
Three lines are shown for 3 different concentrations of the
drug. DXR exposure followed by DDP was less efficacious
than, or the same as, simultaneous exposure. In contrast,
exposure to DDP followed by DXR was more efficacious;
the best cell kill with a 1 h interval between each drug.
Increasing time intervals from DDP to DXR for longer than
1 h resulted in a gradual diminution of the potentiation.
The influence of MTS density on time-dependent cell
lethality of DXR plus DDP combination is shown in Figure
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Figure 1 Influence of the density of PC-10 squamous carcinoma
multicellular tumor spheriods on doxorubicin (panel a) or cis-
platin (panel b) - induced cell lethality. Bar, s.d.
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Figure 2 Time-dependent cell lethality of doxorubicin plus cis-
platin on multicellular tumour spheriods. Three different con-
centrations of doxorubicin and cis-platin tested are shown on the
right side of each line. Bar, s.d.
3. The differences of the 2 lines on the left half of the panel
indicate weak activity of the combination at high MTS
density when DXR is administered first. When the 2 drugs
were given simultaneously, the survival fractions were nearly
identical, indicative of better expression of DDP activity. For
both low and high MTS densities, the best cell kill sequence
of this combination was DDP followed by DXR with a 1 h
interval between the 2 drugs. When the interval between
DDP followed by DXR widened, the 2 lines began to
separate again, suggesting the same effect of MTS density
seen when DXR was given first.
Examples of the median effect plot analysis from the
combination- DXR followed 24h later by DDP, simulta-
neous exposure of the 2 drugs and DDP followed 1 h later
by DXR - are shown in Figure 4. All of these 3 lines
showed synergistic interactions; among them, the DDP expo-
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Table I Influence of the pretreatment with different
concentrations of cis-platin on doxorubicin-induced
cell lethality. Data are shown as survival fraction in
percentage compared to doxorubicin alone control
( s.d.)
Multicellular
Cis-platin (Al) Monolayer tumour spheroids
0 100.Oa 100.0b
I x 10-9 103.4+0.9 ND
1x 10-8 103.4+1.5 86.0 +7.8
1 x 10-7 92.9+6.5 71.7*+3.8
1 x 10-6 84.9+7.7 63.7*+9.6
a1 X 10-6M doxorubicin alone; b2X 10-5M doxo-
rubicin alone; *The asterisks indicate significant
(P<0.05) decrease in survival fraction as compared to
doxorubicin alone control; ND, not done.
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Figure 3 Influence of the density of multicellular tumour spher-
oids on time-dependent cell lethality of doxorubicin plus cis-
platin. The line for the low density of multicellular tumour
spheroids (2MTS ml-1) was taken from Figure 2. Drug concent-
rations used were doxorubicin 2 x 10- 5 M and cis-platin
2xl0-5M. Bar, s.d.
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Figure 5 Panel a shows doxorubicin fluorescence of spheroid
cross-section after 1 h exposure to the compound alone. Panel b
shows doxorubicin fluorescence of spheroid cross-section after
pre-treatment with cis-platin.
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Figure 4 Time-dependent combination effects of doxorubicin
plus cis-platin against multicellular tumour spheroids expressed
as combination index.
sure, followed 1 h later by DXR, was the most efficacious
sequence.
Pretreatment with low concentrations of DDP, which was
non-toxic to cells in monolayer, also produced increased
DXR-induced cell kill:
I x 10-7 M DDP produced a decrease
in surviving fraction up to 30% for cells in MTS (Table I).
These results indicate that DXR penetration was enhanced
by non-toxic concentrations of cis-platin and that the
penetration-enhancing effects can be separable from the
cytotoxic effects of the compound.
Fluorescent microscopic observations of DXR penetration
into MTS are illustrated in Figure 5. When MTS were
exposed to DXR alone, DXR fluorescence was seen in only
a few outerlayer(s) of the MTS. When MTS were exposed to
DDP I h previously - the best cell kill sequence - DXR
fluorescence was seen within the entire layers of the MTS
(Figure 5, Panel b).
Discussion
MTS have certain characteristics similar to de novo solid
tumours (Allison et al., 1983; Franko & Sutherland, 1979;
Freyer & Sutherland, 1980; Nederman et al., 1984; Suther-
land & Durant, 1973; Yuhas et al., 1977,1978). They contain
such extracellular matrix as fibronectin, laminin and collagen
(Nederman & Twentyman, 1984), comprise a chronically
hypoxic cell population in the core (Franko & Sutherland,
1979; Sutherland & Durant, 1973) and show heterogenous
cell cycle times (Allison et al., 1983; Freyer & Sutherland,
1980). For these reasons, MTS have been used as an in vitro
model to study the effects of radiation (Allison et al., 1983;
Franko & Sutherland, 1979; Freyer & Sutherland, 1980;
Sasaki et al., 1984a; Sutherland & Durant, 1973) and
chemotherapeutic agents (Erlichman & Vidgen, 1984; Kerr et
al., 1986; Nederman & Twentyman, 1984; Sasaki et al.,
1984b; West et al., 1980).
Our data show that the density of MTS influences the cell
kill effect of certain drugs. The higher the density of MTS,
the lesser the cell kill effect of DXR. The concept of
inoculum effect seen at a single cell level could thus be
extended to the density of MTS. Since solid tumour masses
in vitro do not grow more than 300-400pm in diameter
without a blood supply (Folkman, 1986; Kolstad, 1968), we
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have assumed that a large clinically recognizable tumour
mass with neovasculature is equivalent to MTS in high
density. The DDP-induced cell kill effect seemed to follow
first order kinetics irrespective of MTS density, indicating
good drug penetration into the MTS core. In contrast, the
cell kill effect of DXR was progressively less efficacious at
higher drug concentrations as a consequence of poor drug
penetration.
The combination study herein presented shows that
sequencing DDP and DXR influenced the cell kill effect at a
tumour mass level. As seen in Figure 4, DDP plus DXR was
always synergistic, with the exception of very low concen-
trations of the drugs. With increasing effect levels the
combination index was progressively lower indicating heigh-
tened synergism. The drug sequencing studies showed that
the best cell kill sequence was DDP first with a 1 h interval
before DXR exposure. The increased synergistic interaction
of this sequence was shown to be due to an increased
population of cells in MTS at risk.
In attempts to elucidate the mechanism of the heightened
cell kill effect from this sequence, we evaluated whether
DDP could influence cell lethality and penetration of DXR.
Pretreatment of DDP increased DXR-induced cell lethality
even at non-toxic low concentration levels for MTS. This
was not observed for monolayers. For fluorescent micro-
scopy study, DXR concentrations of .2 x 10-5 M were
necessary in order to detect the fluorescence. Exposure to
DXR alone resulted in DXR fluorescence only on one or
two outer layer(s) of the MTS (Inoue et al., 1985). When
MTS were exposed to DDP and DXR in this sequence,
DXR fluorescence was seen throughout the MTS, indicating
good penetration of DXR. The precise mechanism of DDP-
induced improvement in DXR penetration is unclear. Other
workers indicated that drug penetration into MTS is
influenced by (a) cell to cell interaction in MTS, (b) molecu-
lar size of the drug, (c) liquid solubility of the drug and (d)
intraspheroidal pH gradients (Erlichman & Vidgen, 1984;
Kerr et al., 1986). It is likely that DDP exposure changed
cell-to-cell interactions within the MTS, making it easier for
DXR to penetrate into the core. While the interaction
between DDP and cell membrane is poorly understood, it
has been observed that the compound binds with cell surface
DNA, leading to the loss of the nucleic acid (Juckett &
Rosenberg, 1982). Erlichman and Vidgen (1984) reported
that avid binding of DXR to the outer layer of MTS
inhibited penetration of the drug into the core. It is possible
that the avid binding of DXR to cell surface material such
as DNA was inhibited by pretreatment with DDP.
Theoretical and practical aspects of combination chemo-
therapy at a single cell level have been discussed by Sartorelli
and Creasey (1982). Little information has so far been
provided, however, on the approach with combination
chemotherapy at the tumour mass level. Sensitivity of a cell
to DXR and DDP is known to be highly related to the
intracellular drug concentration (Eichholtz-Wirth & Hietel,
1986; Iliakis & Lazor, 1987). Any means to increase the drug
penetration into MTS should improve drug concentration
within the cells in the MTS core.
Our observations indicate that initial treatment with DDP
resulted in increased efficacy for DXR at the tumour mass
level. Clinical, toxicological and pharmacological trials of
DDP followed by DXR are warranted.
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